ID

29915

Beschreibung

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine; ODM derived from: https://clinicaltrials.gov/show/NCT00626743

Link

https://clinicaltrials.gov/show/NCT00626743

Stichworte

  1. 27.04.18 27.04.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. April 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT00626743

Eligibility Hypertension NCT00626743

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male subjects 19-65 years of age inclusive
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
subjects with hypertension as defined 100 mmhg ≤ sbp<140 mmhg and 65 mmhg ≤ dbp < 90 mmhg after more than 5 minutes in the supine position
Beschreibung

Hypertensive disease | Lying systolic blood pressure | Lying diastolic blood pressure

Datentyp

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C1319895
UMLS CUI [3]
C1319896
written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
willing and able to comply with the requirements of the protocol
Beschreibung

Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects with acute or chronic disease within 4 weeks of study initiation.
Beschreibung

Acute Disease | Chronic disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0001314
UMLS CUI [2]
C0008679
subejcts with any gastrointestinal disorders known to alter drug absorption(except appendectomy, herniotomy, etc.)
Beschreibung

Gastrointestinal Diseases Changing Drug absorption | Exception Appendectomy | Exception Herniotomy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0392747
UMLS CUI [1,3]
C0678745
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003611
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0405600
subjects with any clinically significant allergic disease or with a known allergy to the pde5 inhibitors
Beschreibung

Hypersensitivity | Hypersensitivity Phosphodiesterase 5 inhibitor

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1318700
subjects with clinically significant abnormalities on laboratory tests
Beschreibung

Laboratory test result abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0438215
subjects with orthostatic hypotension defined as a fall in systolic blood pressure of at least 20 mmhg or diastolic blood pressure of at least 10 mmhg when a person assumes a standing position
Beschreibung

Hypotension, Orthostatic | Standing systolic blood pressure Decreased | Standing diastolic blood pressure Decreased

Datentyp

boolean

Alias
UMLS CUI [1]
C0020651
UMLS CUI [2,1]
C1303018
UMLS CUI [2,2]
C0205216
UMLS CUI [3,1]
C1303019
UMLS CUI [3,2]
C0205216
subjects with abnormal qtc interval(≥440ms)
Beschreibung

QTc interval Abnormal

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0489625
UMLS CUI [1,2]
C0205161
subjects with color-blindness or weakness
Beschreibung

Color blindness | Weakness

Datentyp

boolean

Alias
UMLS CUI [1]
C0242225
UMLS CUI [2]
C3714552
subejcts with alcohol, drug or caffeine abuse
Beschreibung

Substance Use Disorders | Caffeine abuse

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0679260
diet known to alter drug absorption, distribution, metabolism or elimination processes
Beschreibung

Diet Changing Drug absorption | Diet Changing Drug distribution | Diet Changing Drug metabolism | Diet Changing Drug elimination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012155
UMLS CUI [1,2]
C0392747
UMLS CUI [1,3]
C0678745
UMLS CUI [2,1]
C0012155
UMLS CUI [2,2]
C0392747
UMLS CUI [2,3]
C0870449
UMLS CUI [3,1]
C0012155
UMLS CUI [3,2]
C0392747
UMLS CUI [3,3]
C0683140
UMLS CUI [4,1]
C0012155
UMLS CUI [4,2]
C0392747
UMLS CUI [4,3]
C0683141
subjects who participated in other clinical studies within 2 months before an administration
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
other subjects who are ineligible for the study at the discretion of the principle investigator or sub-investigators
Beschreibung

Study Subject Participation Status Ineligible

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1512714

Ähnliche Modelle

Eligibility Hypertension NCT00626743

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
male subjects 19-65 years of age inclusive
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Hypertensive disease | Lying systolic blood pressure | Lying diastolic blood pressure
Item
subjects with hypertension as defined 100 mmhg ≤ sbp<140 mmhg and 65 mmhg ≤ dbp < 90 mmhg after more than 5 minutes in the supine position
boolean
C0020538 (UMLS CUI [1])
C1319895 (UMLS CUI [2])
C1319896 (UMLS CUI [3])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
willing and able to comply with the requirements of the protocol
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acute Disease | Chronic disease
Item
subjects with acute or chronic disease within 4 weeks of study initiation.
boolean
C0001314 (UMLS CUI [1])
C0008679 (UMLS CUI [2])
Gastrointestinal Diseases Changing Drug absorption | Exception Appendectomy | Exception Herniotomy
Item
subejcts with any gastrointestinal disorders known to alter drug absorption(except appendectomy, herniotomy, etc.)
boolean
C0017178 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0003611 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0405600 (UMLS CUI [3,2])
Hypersensitivity | Hypersensitivity Phosphodiesterase 5 inhibitor
Item
subjects with any clinically significant allergic disease or with a known allergy to the pde5 inhibitors
boolean
C0020517 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1318700 (UMLS CUI [2,2])
Laboratory test result abnormal
Item
subjects with clinically significant abnormalities on laboratory tests
boolean
C0438215 (UMLS CUI [1])
Hypotension, Orthostatic | Standing systolic blood pressure Decreased | Standing diastolic blood pressure Decreased
Item
subjects with orthostatic hypotension defined as a fall in systolic blood pressure of at least 20 mmhg or diastolic blood pressure of at least 10 mmhg when a person assumes a standing position
boolean
C0020651 (UMLS CUI [1])
C1303018 (UMLS CUI [2,1])
C0205216 (UMLS CUI [2,2])
C1303019 (UMLS CUI [3,1])
C0205216 (UMLS CUI [3,2])
QTc interval Abnormal
Item
subjects with abnormal qtc interval(≥440ms)
boolean
C0489625 (UMLS CUI [1,1])
C0205161 (UMLS CUI [1,2])
Color blindness | Weakness
Item
subjects with color-blindness or weakness
boolean
C0242225 (UMLS CUI [1])
C3714552 (UMLS CUI [2])
Substance Use Disorders | Caffeine abuse
Item
subejcts with alcohol, drug or caffeine abuse
boolean
C0038586 (UMLS CUI [1])
C0679260 (UMLS CUI [2])
Diet Changing Drug absorption | Diet Changing Drug distribution | Diet Changing Drug metabolism | Diet Changing Drug elimination
Item
diet known to alter drug absorption, distribution, metabolism or elimination processes
boolean
C0012155 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C0012155 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0870449 (UMLS CUI [2,3])
C0012155 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0683140 (UMLS CUI [3,3])
C0012155 (UMLS CUI [4,1])
C0392747 (UMLS CUI [4,2])
C0683141 (UMLS CUI [4,3])
Study Subject Participation Status
Item
subjects who participated in other clinical studies within 2 months before an administration
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status Ineligible
Item
other subjects who are ineligible for the study at the discretion of the principle investigator or sub-investigators
boolean
C2348568 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video